What is the market doing?
What the tape says about LGND
Ligand Pharmaceuticals Incorporated is +97% over the past year while the S&P 500 is +23%: 74 points ahead of the market.
+97%
1-year return · S&P 500 +23%
- vs 200-day average
- +29%
vs 200-day average · a clear uptrend
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- −9.0%
Below its 52-week high
Details›
- Last close2026-08-26
- $287.86
- 1 monthS&P 500 +3.7%
- −4.7%
- 1 yearS&P 500 +23%
- +97%
- 5 yearsS&P 500 +87%
- +316%
- vs 50-day average$279.50
- +3.0%
- 52-week high
- $316.44
- 52-week low
- $147.01
- Annualised volatility
- 38%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$5.6M
| Year | Return |
|---|---|
| 2026 (year to date) | +52% |
| 2025 | +76% |
| 2024 | +50% |
| 2023 | +6.9% |
| 2022 | −31% |
| 2021 | +55% |
| 2020 | −4.6% |
| 2019 | −23% |
| 2018 | −0.90% |
| 2017 | +35% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +7.5% |
| Feb | 10 | 6 of 10 | −1.2% |
| Mar | 10 | 7 of 10 | −1.6% |
| Apr | 10 | 6 of 10 | +3.2% |
| May | 10 | 4 of 10 | −0.61% |
| Jun | 10 | 9 of 10 | +8.9% |
| Jul | 11 | 7 of 11 | +2.8% |
| Aug | 11 | 5 of 11 | +1.9% |
| Sep | 10 | 5 of 10 | +0.68% |
| Oct | 10 | 6 of 10 | −3.6% |
| Nov | 10 | 8 of 10 | +7.9% |
| Dec | 10 | 3 of 10 | −1.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.